Tablet RYBELSUS is a patented oral formulation of semaglutide, manufactured by Novo Nordisk. It is the first GLP-1 receptor agonist available in oral form and is used primarily for the management of Type 2 Diabetes Mellitus. Currently, there is no substitute available in India.
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Hormonal Imbalances
Reasons for flagging
Hateful or abusive contentSpam or misleadingAdvertisement